Vagus Nerve Support Thera pH™
Thera pH ™ contains ingredients needed to both promote normal urine chemistry and maintain a natural alkaline state.
Why is normal urine chemistry important?
Normal urine chemistry is necessary to avoid the formation of kidney stones. Normal urine chemistry involves a balance of minerals and controlled levels of oxalate, calcium, uric acid, and phosphorus in urine. When these levels increase abnormally or become imbalanced, a kidney stone can result.
What causes kidney stones?
Normally, oxalate, calcium, uric acid, and phosphorus is excreted through the urine. When the amounts of these substances are too high, they can accumulate as crystals and ultimately form a kidney stone.
What increases the risk of kidney stones?
Obesity, dehydration, diets high in protein and fat, weight gain, some medical conditions (such as hyperparathyroidism, gout, inflammatory bowel disorders, and gastric bypass surgery), and some medications (such as acetazolamide) can encourage the formation of kidney stones. To prevent kidney stones, it is important to reduce urinary oxalate and increase citrate levels in the urine.
Research shows the ingredients in Thera pH™ can result in a 29% reduction in urinary oxalate levels, a 48% increase in both citrate and magnesium levels, and a 22% reduction in calcium oxalate levels. Support your magnesium levels while maintaining normal urine chemistry and an alkaline state.
Want to minimize the risk of kidney stones?
Barcelo, P, et al. “Randomized Double-Blind Study of Potassium Citrate in Idiopathic Hypocitraturic Calcium Nephrolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Dec. 1993.
Ettinger, B, et al. “Potassium-Magnesium Citrate Is an Effective Prophylaxis against Recurrent Calcium Oxalate Nephrolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Dec. 1997.
Eisner, B H, et al. “High Dietary Magnesium Intake Decreases Hyperoxaluria in Patients with Nephrolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Oct. 2012.
OUR INGREDIENTS
Vagus Nerve Support™ Thera pH™contains only the ingredients clinically proven to help normalize urine chemistry.
Magnesium CitrateMagnesium is associated with decreasing hyperoxaluria in the population with kidney stone formation. Magnesium is also necessary for over 300 biochemical actions in the body, in addition to normal muscle and nerve function. |
Potassium CitratePotassium citrate is effective in the prevention of calcium oxalate kidney stones.
|
Calcium CitrateCalcium citrate is the preferred calcium supplement for people at risk of stone formation because it helps to increase urinary citrate excretion. |
Vitamin B6 (Pyridoxine)Vitamin B6 is not only necessary for the formation of neurotransmitters (including GABA, dopamine, serotonin, epinephrine, and norepinephrine), it has also been shown to reduce the risk of kidney stones.
|
Benefits of Vagus Nerve Support Thera pH™
Thera pH™ has been specially formulated to provide the substrates necessary for maximal urine chemistry. Normal urine chemistry is necessary to avoid the formation of kidney stones. Additionally, Thera pH™ contains ingredients that promote the normal production of neurotransmitters (including serotonin, epinephrine, dopamine, GABA, and norepinephrine) and the normal growth of bones and nerves.
How does Vagus Nerve Support Thera pH™ promote an alkaline state?
The ingredients in Thera pH ™ promote alkalinity. Why is this important? If you want to avoid kidney stones, drinking water and staying fully hydrated is one of the first things to consider. Next is utilizing citrate electrolytes to help maintain normal urine chemistry necessary to avoid kidney stones (both calcium oxalate and uric acid stones). Thera pH™ contains a blend of magnesium citrate, calcium citrate, and potassium citrate that has been clinically proven to help maintain normal body pH levels and avoid the acidosis that can encourage kidney stone formation.
When taking medications such as acetazolamide or topiramate, a change in urinary pH can occur, increasing the risk of kidney stones. The shift of pH toward acidic levels can encourage renal tubular acidosis, promoting kidney stone formation.
Thera pH™ is specially formulated to promote an alkaline
References
Barcelo, P, et al. “Randomized Double-Blind Study of Potassium Citrate in Idiopathic Hypocitraturic Calcium Nephrolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Dec. 1993, www.ncbi.nlm.nih.gov/pubmed/8230497.
Curhan, G C, et al. “A Prospective Study of the Intake of Vitamins C and B6, and the Risk of Kidney Stones in Men.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, June 1996, www.ncbi.nlm.nih.gov/pubmed/8618271.
Curhan, G C, et al. “Intake of Vitamins B6 and C and the Risk of Kidney Stones in Women.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Apr. 1999, www.ncbi.nlm.nih.gov/pubmed/10203369.
Eisner, B H, et al. “High Dietary Magnesium Intake Decreases Hyperoxaluria in Patients with Nephrolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Oct. 2012, www.ncbi.nlm.nih.gov/pubmed/22921695.
Ettinger, B, et al. “Potassium-Magnesium Citrate Is an Effective Prophylaxis against Recurrent Calcium Oxalate Nephrolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Dec. 1997, www.ncbi.nlm.nih.gov/pubmed/9366314.
Kato, Y, et al. “Changes in Urinary Parameters after Oral Administration of Potassium-Sodium Citrate and Magnesium Oxide to Prevent Urolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Jan. 2004, www.ncbi.nlm.nih.gov/pubmed/14751336.
Lindberg, J, et al. “Effect of Magnesium Citrate and Magnesium Oxide on the Crystallization of Calcium Salts in Urine: Changes Produced by Food-Magnesium Interaction.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Feb. 1990, www.ncbi.nlm.nih.gov/pubmed/2299712.
Massey, L. “Magnesium Therapy for Nephrolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, June 2005, www.ncbi.nlm.nih.gov/pubmed/16100850.
Ortiz-Alvarado, O, et al. “Pyridoxine and Dietary Counseling for the Management of Idiopathic Hyperoxaluria in Stone-Forming Patients.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, May 2011, www.ncbi.nlm.nih.gov/pubmed/21334732.
Pak, C Y, et al. “Physicochemical Action of Potassium-Magnesium Citrate in Nephrolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Mar. 1992, www.ncbi.nlm.nih.gov/pubmed/1585829.
Rao, T. V. R. K., and V. K. Choudhary. “Effect of pyridoxine (Vitamin-B6) supplementation on calciuria and oxaluria levels of some normal healthy persons and urinary stone patients.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, July 2005, www.ncbi.nlm.nih.gov/pmc/articles/PMC3453845/.
Rattan, V, et al. “Effect of Combined Supplementation of Magnesium Oxide and Pyridoxine in Calcium-Oxalate Stone Formers.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/7992461.
Reddy, S.V. Krishna, et al. “Effect of Potassium Magnesium Citrate and Vitamin B-6 Prophylaxis for Recurrent and Multiple Calcium Oxalate and Phosphate Urolithiasis.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, June 2014, www.ncbi.nlm.nih.gov/pmc/articles/PMC4064051/.
Robinson, M R, et al. “Impact of Long-Term Potassium Citrate Therapy on Urinary Profiles and Recurrent Stone Formation.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Mar. 2009, www.ncbi.nlm.nih.gov/pubmed/19152932.
Sakhaee, K, et al. “Contrasting Effects of Various Potassium Salts on Renal Citrate Excretion.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Feb. 1991, www.ncbi.nlm.nih.gov/pubmed/1899422.
Zimmermann, D J, et al. “Importance of Magnesium in Absorption and Excretion of Oxalate.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, www.ncbi.nlm.nih.gov/pubmed/15812215.
What our Customers are Saying About
Vagus Nerve Support Thera pH™
Gentle and Safe Ingredients
Vagus Nerve Support Thera pH ™ is thoroughly tested to be both gentle and effective. It is free from gluten, corn, salt, sucrose, starch, nuts, yeast, artificial flavors or colors.
All ingredients have been tested by the FDA and have been found to be “Generally Regarded As Safe (GRAS)”. In addition, our manufacturing facilities are strictly audited for compliance with Good Manufacturing Policies (GMP’s).
All ingredients are carefully processed to preserve chemical complexity, ensure purity, and maintain efficacy. We test every batch to ensure each and every bottle is pure and free from contaminants. You can be sure you are receiving the best in nutritional supplementation.
Commitment to Quality
At TJ Nutrition®, We Have An Unwavering Commitment To Quality
We always go beyond the FDA’s required product testing to ensure you receive the highest quality supplement possible. Our manufacturing facilities are third party certified by industry watchdog organizations such as NSF and NPA, which means they have been strictly audited for compliance with Good Manufacturing Practices (GMP’s).
All ingredients are carefully processed to preserve chemical complexity, ensure purity, and maintain efficacy. We test every batch to ensure each and every bottle is pure and free from contaminants. You can be sure you are receiving the best in nutritional supplementation.